- Bristol Myers Squibb (San Diego, CA)
- …BMS. RayzeBio is developing innovative drugs against targets of solid tumors. The lead asset, RYZ101, is in Phase 3 testing for patients with gastroenteropancreatic ... clinical applications to advance novel Radiopharmaceutical Oncology therapies. As a translational scientist you will develop and execute in vitro, ex vivo, and in… more
- Bristol Myers Squibb (San Diego, CA)
- …BMS. RayzeBio is developing innovative drugs against targets of solid tumors. The lead asset, RYZ101, is in Phase 3 testing for patients with gastroenteropancreatic ... context of oncology targets to support the screening, characterization, and lead -identification of novel RPT agents. + Conduct routine screening experiments using… more